|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Herbst RS, Heymach JV and Lippman SM: Lung
cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Imielinski M, Berger AH, Hammerman PS,
Hernandez B, Pugh TJ, Hodis E, Cho J, Suh J, Capelletti M,
Sivachenko A, et al: Mapping the hallmarks of lung adenocarcinoma
with massively parallel sequencing. Cell. 150:1107–1120. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Peng F, Li H, Ning Z, Yang Z, Li H, Wang
Y, Chen F and Wu Y: CD147 and prostate cancer: a systematic review
and meta-analysis. PLoS One. 11:e0163672016. View Article : Google Scholar
|
|
7
|
Toh CK, Gao F, Lim WT, Leong SS, Fong KW,
Yap SP, Hsu AA, Eng P, Koong HN, Thirugnanam A and Tan EH:
Never-smokers with lung cancer: epidemiologic evidence of a
distinct disease entity. J Clin Oncol. 24:2245–2251. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Subramanian J and Govindan R: Lung cancer
in never smokers: a review. J Clin Oncol. 25:561–570. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gavelli G and Giampalma E: Sensitivity and
specificity of chest X-ray screening for lung cancer: review
article. Cancer. 89 Suppl:2453–2456. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao Z, Li S, Song E and Liu S: The roles
of ncRNAs and histone-modifiers in regulating breast cancer stem
cells. Protein Cell. 7:89–99. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
OKelly F, Marignol L, Meunier A, Lynch TH,
Perry AS and Hollywood D: MicroRNAs as putative mediators of
treatment response in prostate cancer. Nat Rev Urol. 9:397–407.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou L, Zhao LC, Jiang N, Wang XL, Zhou
XN, Luo XL and Ren J: MicroRNA miR-590-5p inhibits breast cancer
cell stemness and metastasis by targeting SOX2. Eur Rev Med
Pharmacol Sci. 21:87–94. 2017.PubMed/NCBI
|
|
14
|
Feng Y, Liu J, Kang Y, He Y, Liang B, Yang
P and Yu Z: miR-19a acts as an oncogenic microRNA and is
up-regulated in bladder cancer. J Exp Clin Cancer Res. 33:672014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: a Bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Posada D and Buckley TR: Model selection
and model averaging in phylogenetics: advantages of Akaike
information criterion and Bayesian approaches over likelihood ratio
tests. Syst Biol. 53:793–808. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chang L, Guo F, Huo B, Lv Y, Wang Y and
Liu W: Expression and clinical significance of the microRNA-200
family in gastric cancer. Oncol Lett. 9:2317–2324. 2015.PubMed/NCBI
|
|
19
|
Liu J, Pang Y, Wang H, Li Y, Sun X, Xu F,
Ren H and Liu D: miR-101 inhibits the proliferation and migration
of breast cancer cells via downregulating the expression of DNA
methyltransferase 3a. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi.
32:299–303. 2016.(In Chinese). PubMed/NCBI
|
|
20
|
Fan P, Liu L, Yin Y, Zhao Z, Zhang Y,
Amponsah PS, Xiao X, Bauer N, Abukiwan A, Nwaeburu CC, et al:
MicroRNA-101-3p reverses gemcitabine resistance by inhibition of
ribonucleotide reductase M1 in pancreatic cancer. Cancer Lett.
373:130–137. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cao K, Li J, Zhao Y, Wang Q, Zeng Q, He S,
Yu L, Zhou J and Cao P: miR-101 inhibiting cell proliferation,
migration and invasion in hepatocellular carcinoma through
downregulating Girdin. Mol Cell. 39:96–102. 2016. View Article : Google Scholar
|
|
22
|
Zhao Z, Li R, Sha S, Wang Q, Mao W and Liu
T: Targeting HER3 with miR-450b-3p suppresses breast cancer cells
proliferation. Cancer Biol Ther. 15:1404–1412. 2014. View Article : Google Scholar : PubMed/NCBI
|
